Oncodesign Precision Medicine (XPAR:ALOPM) Total Long-Term Assets : €2.05 Mil (As of Dec. 2024)

View and export this data going back to 2022. Start your Free Trial

What is Oncodesign Precision Medicine Total Long-Term Assets?

Total Long-Term Assets includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets. Oncodesign Precision Medicine's Total Long-Term Assets for the quarter that ended in Dec. 2024 was €2.05 Mil.

Oncodesign Precision Medicine Total Long-Term Assets Historical Data

The historical data trend for Oncodesign Precision Medicine's Total Long-Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Oncodesign Precision Medicine Total Long-Term Assets Chart

Oncodesign Precision Medicine Annual Data

Trend

Dec20

Dec21

Dec22

Dec23

Dec24

Total Long-Term Assets

1.20

1.85

1.96

2.23

2.05

Oncodesign Precision Medicine Semi-Annual Data
	Dec20	Dec21	Jun22	Dec22	Jun23	Dec23	Jun24	Dec24
Total Long-Term Assets	Get a 7-Day Free Trial			1.96	2.05	2.23	-	2.05

Oncodesign Precision Medicine Total Long-Term Assets Calculation

Total Long-Term Assets are the sum of the carrying amounts of all assets that are expected to be realized in cash, sold or consumed longer than one year. It includes Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets.

Oncodesign Precision Medicine Total Long-Term Assets Related Terms

Thank you for viewing the detailed overview of Oncodesign Precision Medicine's Total Long-Term Assets provided by GuruFocus.com. Please click on the following links to see related term pages.

Oncodesign Precision Medicine Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Oncodesign Precision Medicine SA (XPAR:ALOPM) » Definitions » Total Long-Term Assets

Comparable Companies

Traded in Other Exchanges

ZR8:Germany

Address

18 rue Jean Mazen, Dijon, FRA, 21000

Website

https://www.opm.oncodesign.com

Oncodesign Precision Medicine SA is a biopharmaceutical company specialised in precision medicine. Its mission is to provide patients with effective diagnostic and therapeutic solutions for resistant and metastatic cancers.

Oncodesign Precision Medicine Headlines

No Headlines